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ABSTRACT 
 
The phenomenon that is known as RNA mediated interference (RNAi) was first observed in the nematode C. 
elegans. The application of RNAi has now been widely disseminated and the mechanisms underlying the 
pathway have been uncovered using both genetics and biochemistry. In the worm, it has been demonstrated 
that RNAi is easily adapted to high throughput analysis and screening protocols. Hence, given the availabil-
ity of whole genome sequences, RNAi has been used extensively as a tool for annotating gene function. Ge-
netic screens performed with C. elegans have also led to the identification of genes that are essential for 
RNAi or that modulate the RNAi process. The identification of such genes has made it possible to manipu-
late and enhance the RNAi response. Moreover, many of the genes identified in C. elegans have been con-
served in other organisms. Thus, opportunities are available for researchers to take advantage of the insights 
gained from the worm and apply them to their own systems in order to improve the efficiency and potency of 
the RNAi response. 
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INTRODUCTION 
 
RNA mediated interference (RNAi) is extensively used as 
a sequence-specific tool for generating knock-down phe-
notypes and examining gene function in a wide variety of 
organisms.  It  also  displays  promise  as  a  technique  for 
therapeutic intervention in human disease. In the nematode 
C. elegans, investigations into the mechanisms underlying 
RNAi were instigated by the paradoxical finding that the 
germline  injection  of  in  vitro  synthesised  RNA  corre-
sponding to either the sense or antisense strand of par-1 
mRNA  mimicked  the  par-1  loss  of  function  phenotype 
(Guo and Kemphues, 1995). The response elicited by ex-
ogenous sense strand par-1 RNA indicated that the inhibi-
tion of cognate par-1 activity could not be caused simply 
by  translational inhibition promoted by base pairing  be-
tween  the  injected  and  endogenous  par-1  mRNA.  The 
resolution of this paradox was provided by Fire and col-
leagues;  they  demonstrated  that  double  stranded  RNA 
(dsRNA) was a substantially more potent agent for inhibit-
ing gene activity than either single-stranded sense or an-
tisense RNA (Fire et al, 1998). It is now known that the 
RNAi pathway of C. elegans shares mechanistic similari-
ties  with  post  transcriptional  gene  silencing  (PTGS)  in 
plants and fungi (Cogoni and Macino, 1999; Baulcombe, 
2004) and homology-dependent gene silencing in higher 
organisms (Hammond et al, 2000; Wianny and Zernicka-
Goetz, 2000). 
 
This review will focus on using RNAi as a tool for analys-
ing gene function, in which the RNAi response is triggered 
by the addition of sequence-specific exogenous dsRNA or 
short interfering RNA (siRNA). In particular, we will de-
scribe how the genetic tractability of C. elegans has been 
used to great advantage not only to identify genes that are 
essential for RNAi, but also to identify genes that modu-
late or negatively regulate the pathway. Because many of 
the key components of the RNAi pathway are conserved 
across phyla, insights gained from the worm have the po-
tential  to  be  translated  to  other  organisms  and  enhance 
both the efficacy and potency of RNAi as a tool for study-
ing  gene  function  (Hamilton  and  Baulcombe,  1999; 
Caplen et al, 2001; Elbashir et al, 2001; Knight and Bass, 
2002; Kennedy et al, 2004; Wang et al, 2005).  
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THE RNAi PATHWAY IN C. ELEGANS 
 
Obviously RNAi is not simply a tool intelligently designed 
for researchers to knockdown gene activity. Moreover, the 
number of processes involving components of the RNAi 
machinery has burgeoned; RNAi is involved in a variety 
of basic physiological responses ranging from the control 
of gene expression to the establishment of heterochromatin 
silencing.  In  C.  elegans,  it  has  been  suggested  that  the 
natural  physiological  function  of  RNAi  is  to  protect  C. 
elegans  against  viral  infection  or  genomic  invasion  by 
transposable elements (Lu et al, 2005; Wilkins et al, 2005). 
It has also been shown that C. elegans transgenes, which 
often form large tandem arrays, can lead to co-suppression 
of  both  the  transgene  and  its  chromosomal  homologue 
through RNAi (Ketting et al, 1999; Dernburg et al, 2000). 
Components of the RNAi machinery also participate in the 
processing of microRNAs (miRNAs),which are considered 
to  be  natural  substrates  for  Dicer  (Zamore  and  Haley, 
2005). It has been shown that miRNAs can target mRNAs 
for  degradation  or  inhibit  the  translation  of  mRNAs  by 
binding to sites in the 3’ UTR (Ambros, 2001; Bagga et al, 
2005). In yeast and Drosophila, RNAi has been shown to 
play  a  role  in  establishing  domains  of  heterochromatin 
(Hall et al, 2002; Volpe et al, 2002; Pal-Bhadra et al, 2004; 
Verdel et al, 2004). Here, however, we will limit our dis-
cussion to the classical pathway of RNAi in C. elegans, 
which is triggered by the addition of exogenous dsRNA.  
    
INITIATION OF RNAi BY dsRNA 
 
The basic mechanics underlying RNAi have been uncov-
ered using a combination of genetic and biochemical stud-
ies in C. elegans and Drosophila. The presence of short 
interfering RNAs (siRNAs) was first observed in plants 
(Hamilton and Baulcombe, 1999). Subsequently, siRNAs 
have been found in Drosophila S2 cell extracts and in C. 
elegans (Hammond et al, 2000; Zamore et al, 2000). In 
mammals, RNAi is initiated by the addition of siRNAs, 
because introducing large dsRNA fragments activate an 
interferon driven inhibition of translation (Samuel, 2001). 
By contrast, both the worm and Drosophila lack an inter-
feron  response,  which  makes  it  is  possible  to  trigger 
RNAi by introducing relatively large  dsRNA fragments 
(500-1000 bp), possibly corresponding to the entire length 
of an mRNA.  
 
How are siRNAs generated from large dsRNA molecules 
in the worm? Screens carried out by Tabara and colleagues 
led to the discovery of the first RNAi deficient (rde) path-
way mutants in C. elegans (Tabara et al, 1999). Two of 
these genes, rde-1 and rde-4, encode interacting proteins; 
rde-4 encodes a dsRNA binding protein and rde-1 encodes 
a  PAZ-PIWI/Argonaute  protein.  RDE-4  appears  to  pro-
mote the specific recognition of foreign dsRNA, because it 
does not interact with mRNA or dsRNA derived from an 
amplification  process,  which  will  be  discussed  below 
(Parrish  and  Fire,  2001).  RDE-4  also  interacts  with  the 
conserved DExH-box helicase, DRH-1 (Figure 1) (Tabara 
et al, 2002). Together these proteins form a complex with 
dicer (DCR-1), a dsRNA specific RNaseIII ribonuclease, 
which  is  responsible  for  cleaving  dsRNA  into  21-25  nt 
siRNAs (Tabara et al, 2002; Meister and Tuschl, 2004). 
RISC NUCLEASE ACTIVITY 
 
Early studies in C. elegans using in situ hybridisation re-
vealed that dsRNA mediated interference led to a marked 
reduction in target mRNA transcripts (Montgomery et al, 
1998). This observation supported the existence of a se-
quence-specific nuclease complex, which was responsible 
for  cleaving  and  degrading  target  mRNA  before  it  was 
translated (Montgomery et al, 1998).  
 
Physical evidence supporting the existence of this complex 
was first obtained using a Drosophila cell-free model sys-
tem to identify a preformed entity with nuclease activity, 
named  RISC  (for  RNAi  induced  silencing  complex).  In 
Drosophila, RISC nuclease activity consists of the proteins 
Tudor-SN,  VIG,  Argonaute  2  and  FXR  bound  together 
with siRNAs (Hammond et al, 2000; Caudy et al, 2002; 
Caudy et al, 2003). C. elegans orthologues of Tudor-SN 
and  VIG,  named  TSN-1  and  VIG-1,  respectively,  have 
been identified  and shown  to  share  similar  functions  as 
Drosophila and mammalian proteins (Figure 1) (Caudy et 
al, 2003). TSN-1contains five staphylococcal/micrococcal 
nuclease domain repeats, the last of which is fused to a 
tudor domain. Although TSN-1 appeared to be an obvious 
candidate for Slicer, the nuclease that cleaves siRNA tar-
geted mRNA, this now appears unlikely. However, TSN-1 
could still play a role in degrading target mRNA; TSN-1 is 
also likely to have activities that are distinct from its par-
ticipation in RISC, because it has both a nuclear and cyto-
solic location and can cleave both RNA and DNA (Caudy 
et al, 2003). VIG-1 carries an RGG box, which is a motif 
involved in RNA binding; however little is known about 
its function in RISC (Caudy et al, 2002).  
 
In Drosophila and mammals, RISC contains a PAZ-PIWI 
Argonaute  protein,  Ago-2.  The  crystal  structure  of  the 
PAZ  domain  of  Ago-2  shows  the  presence  of an  RNA 
binding domain,  which  is  important for siRNA  interac-
tions (Song et al, 2003). Additional structural studies re-
vealed that the PIWI domain contains an RNaseH fold, 
which  makes  it  capable  of  performing  endonucleolytic 
cleavage  of  mRNA  targeted  by  siRNAs  (Parker  et  al, 
2004;  Song  et  al,  2004).  It  was  further  confirmed  that 
Ago-2 is Slicer through reconstitution studies (Rivas et al, 
2005).  In  C.  elegans,  an  Argonaute  protein  associated 
with RISC has not been identified, although RDE-1 is a 
PAZ-PIWI/ Argonaute protein involved in the initiation of 
RNAi. However, there are 25 predicted PAZ-PIWI homo-
logues in C. elegans, which might act redundantly in RISC 
(Tabara et al, 1999); one of these PAZ-PIWI homologues, 
PPW-1,  is  required  for  germ  line  RNAi    (Figure  1) 
(Tijsterman et al, 2002b). 
 
AMPLIFICATION  AND  THE  PRODUCTION  OF 
SECONDARY siRNA  
 
In C. elegans, RNAi acts catalytically - only a few mole-
cules of dsRNA are required to trigger the silencing of a 
much  larger  amount  of  mRNA  (Fire  et  al,  1998).  Al-
though,  cleavage  of  the  dsRNA  trigger  by  Dicer  into 
siRNAs provides some amplification, it does not fully ac-
count for the stoichiometry of the amplification. In further 
support of an amplification step in C. elegans RNAi, seco-  
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Figure 1. Schematic depiction the RNAi pathway, highlighting the involvement of C. elegans proteins that participate in the 
RNAi response to exogenously introduced dsRNA. Exogenous dsRNA initiates RNAi by being processed into siRNA by the 
Dicer complex, which includes the RNaseIII nuclease DCR-1, the dsRNA binding protein RDE-4, the PAZ-PIWI protein RDE-1 
and the Dicer related helicase DRH-1. RDE-1 binds siRNAs and is proposed to bring them to the next step of the RNAi pathway. 
At this point, siRNA is either degraded by the negative regulator ERI-1 or incorporated into RISC (RNAi induced silencing com-
plex). Other components of RISC include the Tudor-SN related protein TSN-1, VIG-1 and possibly an unidentified PAZ-
PIWI/Argonaute related protein (please see text for details). RISC then targets and cleaves the mature mRNA. Another complex 
containing either the RRF-1 (somatic) or EGO-1 (germ line) RdRP (RNA-dependent RNA polymerase) and RDE-3 uses siRNAs 
to amplify the target mRNA to produce additional dsRNA, which in turn is processed by the Dicer complex to form secondary 
siRNAs. The secondary siRNAs associate with RISC to perform transitive RNAi. Amplification could also be facilitated by a 
complex containing MUT-7 and RDE-2. The RRF-3 RdRP, which is not essential for RNAi, is postulated to inhibit RNAi by 
competing for components with RRF-1 or EGO-1. 
 
 
ndary siRNAs that do not correspond to the input dsRNA 
trigger  have  been  discovered.  These  secondary  siRNAs, 
although different to the input trigger dsRNA, are identical 
with 5’ segments of the target mRNA (Sijen et al, 2001). It 
has been shown that siRNAs produced by the dicing of 
exogenous dsRNA can subsequently be used as primers to 
amplify a dsRNA from mRNA targets; the dsRNA thereby 
synthesized can then be presented to Dicer in order to pro-
duce a secondary set of siRNAs, which can cycle back to 
RISC to perform transitive RNAi (Figure 1). 
 
It has been found that two of the four RNA-directed RNA 
polymerases (RdRPs) in C. elegans are essential for the 
RNAi amplification process. In the soma, the RdRP family 
gene, rrf-1 is required for production of secondary siRNA, 
which involves the priming of the mature target mRNA by 
the primary siRNAs (Sijen et al, 2001). In the germ line of 
C. elegans, the RdRP, EGO-1, plays role similar to RRF-, 
but  also  has  essential  roles  in  Notch  signalling  and 
oogenesis (Smardon et al, 2000).  
The C. elegans MUT-7 protein, which is a putative exori-
bonuclease, and its interaction partner RDE-2 are also re-
quired  in  vivo  for  efficient  RNAi  (Tabara  et  al,  1999); 
these proteins form a complex that increases in size in re-
sponse to RNAi activation (Tops et al, 2005). Both mut-7 
and rde-2 are not only defective in RNAi, but they are also 
defective in transposon silencing as well as co-suppression 
(Tijsterman et al, 2002a; Sijen and Plasterk, 2003). When 
either mut-7 or rde-2 is absent, siRNAs fail to accumulate 
in vivo. In addition, mut-7 and rde-2 function downstream 
of  rde-1  and  rde-4.  Taken  together,  these  observations 
indicate  mut-7  and  rde-2  function  downstream  of  Dicer 
and  upstream  of  RISC,  and  are  possibly  involved  in 
siRNA amplification.  
 
Another  mutant  that  fails  to  accumulate  siRNAs  and  is 
also proposed to function in siRNA amplification is rde-3. 
RDE-3 is member of the polymerase β nucleotidyltrans-
ferase superfamily. It has been proposed that RDE-3 might 
function by polyadenylating and stabilising the 5’ mRNA  
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cleavage product generated when RISC is associated with 
primary siRNAs; in turn, the stabilised RNA could act as a 
template for an RdRP to generate secondary siRNAs (Fig-
ure 1) (Chen et al, 2005). 
 
rrf-3,  THE  FIRST  ENDOGENOUS  INHIBITOR  OF 
RNAi 
 
It is clear that RNAi is a powerful tool for analysing gene 
function, but as with any technique, there is always room 
for  improvement  or  modification.  Previous  studies  and 
anecdotal reports have shown that the nervous system of 
C. elegans is partially resistant to RNAi (Timmons et al, 
2001).  High  throughput  RNAi  screens  performed  using 
wild type  C. elegans (N2 Bristol) have also  highlighted 
areas in which the efficacy of RNAi is sometimes limited. 
For example, 10% of the genes analysed displayed loss-of-
function phenotypes; however, many genes that had previ-
ously been shown to have essential functions, particularly 
those that function in the nervous system, appeared to be 
less  susceptible  to dsRNA  inhibition when administered 
by feeding or soaking (Fraser et al, 2000; Gonczy et al, 
2000; Maeda et al, 2001; Timmons et al, 2001; Piano et al, 
2002). In addition, it has been revealed that the consisten-
cy and reproducibility of high throughput RNAi screens 
could  be  improved  by  making  weak  or  marginal  RNAi 
responses more robust. 
 
In the course of analysing activities of the four RdRP en-
coding genes in C. elegans, it was observed that an rrf-3 
deletion  mutant  displayed  increased  sensitivity  to  RNAi 
(Sijen et al, 2001). Large-scale screens using rrf-3 mutant 
animals confirmed that the absence of rrf-3 activity led to 
an obvious enhancement in the sensitivity of a range of 
target genes, including neuronal genes, to RNAi (Simmer 
et al, 2002). One hypothesis is that RRF-3 normally has an 
inhibitory  effect  on  RNAi  because it competes with the 
somatic  RRF-1  or  germline  EGO-1  RdRPs  for  dsRNA 
substrates  (Figure  1)  (Simmer  et  al,  2002).  Despite  the 
essential role for the EGO-1 RdRP in the germ line of C. 
elegans, genes encoding RdRP orthologues have not been 
found in either  the Drosophila  or  mammalian genomes, 
although an RdRP activity has been identified in mouse 
erthyroleukaemia cells (Volloch et al,  1987; Stein et al, 
2003). It is possible that another RNA polymerase could 
perform the activity of an absent RdRP, however, it is also 
possible that mammalian cells do not require an amplifica-
tion step for effective RNAi. In C. elegans, the absence of 
rrf-1  mediated amplification  can be  partially  suppressed 
by  knocking  out  eri-1,  an  RNAi  antagonist  that  is  de-
scribed in the next section (Kennedy et al, 2004).  
 
eri-1, A CONSERVED ANTAGONIST OF RNAi 
 
The systemic nature of RNAi in C. elegans and plants - the 
ability  of  the  RNAi  effect  to  be  propagated  across  cell 
boundaries - has been exploited to great advantage. Not 
only can RNAi be performed by injecting dsRNA almost 
anywhere in the animal, but it is also possible simply to 
feed  worms  Escherichia  coli  expressing  gene-specific 
dsRNA (Timmons and Fire, 1998) or to soak them in solu-
tions of dsRNA (Tabara et al, 1998). The ease by which 
RNAi can be performed in C. elegans has made it feasible 
to undertake high throughput whole genome screens de-
signed to uncover gene function and aid in genome anno-
tation (Fraser et al, 2000; Gonczy et al, 2000; Maeda et al, 
2001; Timmons et al, 2001; Piano et al, 2002) 
 
The ability to identify  gene mutations capable of either 
inhibiting  or  enhancing  the  effectiveness  of  RNAi  led 
researchers to perform targeted mutant screens aimed at 
identifying additional genes that could enhance the effec-
tiveness of RNAi. One such screen, which was designed 
to identify mutants with enhanced sensitivity to RNAi in 
the  nervous  system  of  C.  elegans,  identified  eri-1 
(Kennedy et al, 2004). The absence of eri-1 activity in-
creased  the  effectiveness  of  RNAi  in  most  tissues,  not 
only the nervous system, although eri-1 is preferentially 
expressed in neurons and the somatic gonad. The ERI-1 
protein is a member of the DEMDh exonuclease subfam-
ily, which belongs to the DEDDh family of exonucleases. 
ERI-1 contains a SAP domain found in DNA binding pro-
teins  and  a  DEDDh-like  3’  →  5’  exonuclease  domain, 
which is also found in RNases such as RNase T and oli-
goribonuclease  (Kennedy  et  al,  2004).  In  vitro  studies 
show that this domain can degrade the 3’ overhangs of 
siRNA  molecules  and  prevent  their  incorporation  into 
RISC (Figure 1);  thus,  ERI-1  could  normally  act  as an 
RNAi  inhibitor  that  reduces  the  degradation  of  target 
mRNA (Kennedy et al, 2004).      
 
eri-1 orthologues have been identified in higher organ-
isms  and  also  appear  to  act  as  inhibitors  of  the  RNAi 
pathway (Table 1). It has been demonstrated that removal 
of meri-1, the mouse orthologue of eri-1, by siRNAi can 
enhance the sensitivity of RNAi (Hong et al, 2005). Mice 
that  carry  the  reporter  plasmid  pCMV-iHBS  produce 
hepatitis  B  virus  serum  antigen  (HBsAg).  However, 
when these mice are injected with siRNAs corresponding 
to meri-1 and HBVP, a significant decrease in both the 
secretion of HBsAg and in the level of meri-1 transcript 
are observed, when compared to a similar cohort treated 
only with siRNAs to target HBVP. So, as in C. elegans, 
it  appears  that  inhibition  of  meri-1  enhances  RNAi. 
Moreover,  when  mice  were  exposed  to  high  doses  of 
siRNA, meri-1 expression was up-regulated, suggesting 
increased degradation of siRNA with greater concentra-
tions of siRNA.  
 
In humans, the eri-1 orthologue, 3’hExo, is involved in 
processing histone mRNAs with stem-loop structures, and 
is a major regulator of histone mRNA biogenesis and me-
tabolism (Dominski et al, 2003). It has also been demon-
strated  that  siRNAs  are  also  a  substrate  for  3’hExo 
(Kennedy et al, 2004). When HeLa cells are co-transfected 
with both a minigene that expresses the T cell receptor-β 
(TCR-β)  and  a  transgene  that  expresses  a  short  hairpin 
RNA (shRNA) that targets the RNAi-mediated degrada-
tion of TCR-β mRNA, overexpression of 3’hExo increases 
the degradation of TCR-β mRNA by 8-fold (Buhler et al, 
2005).  Taken  together,  these  results  indicate  ERI-1, 
MERI-1  and  3’hExo  share  a  conserved  function  as  an 
siRNase. The identification of eri-1 in C. elegans and its 
conservation as a siRNase in RNAi, suggests that elimina-
tion of eri-1 in mammalian cells could increase the effi-
cacy of RNAi in these systems.  
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SYSTEMIC RNAi IN C. ELEGANS  
 
The systemic nature of C. elegans RNAi was already fully 
realised  in  the  original  report for  Fire  et  al.  (1998).  To 
identify  genes  that  facilitate  systemic  RNAi,  directed 
screens were performed by two groups and sid-1 (systemic 
RNAi  defective)/rsd-8  (RNAi  spreading  defective)  was 
obtained (Winston et al, 2002; Tijsterman et al, 2004). sid-
1 encodes a 776 amino acid protein, containing 11 trans-
membrane  domains  and  a  large  extracellular  N-terminal 
domain (Winston et al, 2002; Tijsterman et al, 2004). sid-1 
localises to the cell periphery in cells exposed to the envi-
ronment, including some but not all neurons, and is essen-
tial for cell-autonomous RNAi in C. elegans (Winston et 
al, 2002; Tijsterman et al, 2004). Transfection of SID-1 
into Drosophila S2 cells reveals that SID-1 promotes the 
import of dsRNA in a process that is based on passive dif-
fusion (Feinberg and Hunter, 2003). It has also been pro-
posed  that  sid-1  could  indirectly  promote  the  uptake  of 
dsRNA by modifying the properties of some other trans-
porter.  The  molecule  being  transported  appears  to  be 
dsRNA and not siRNA (Tijsterman et al, 2002a). The effi-
ciency of this transport system appears to be dependent on 
the length of dsRNA; longer dsRNAs are transported with 
greater  efficiency  than  21  bp  siRNAs  (Feinberg  and 
Hunter, 2003). 
 
Orthologues  of  SID-1  have  been  found  in  insects  and 
mammals. It has recently been demonstrated that systemic 
RNAi gene silencing also exists in the grasshopper, Schis-
tocerca americana. Injection into the dorsal heart vessel of 
first instar nymphs of dsRNA to the vermillon (Sa_v) gene, 
which confers eye colour, resulted in red eye colouration 
consistent with an RNAi knockdown (Dong and Friedrich, 
2005).  The  presence  of  a  ubiquitously  expressed  sid-1 
homologue  (Sa_sid-1)  suggests  that  sid-1  might  play  a 
conserved role in mediating systemic RNAi in animals.  
 
The mammalian sid-1 homologue, SIDT1, which similarly 
encodes a  protein with  11  predicted  transmembrane  do-
mains, also localises at the cell periphery (Duxbury et al, 
2005). By contrast to Ce-SID-1, which does not transport 
siRNAs  very  efficiently,  overexpression  of  SIDT1  in-
creases the uptake of siRNA via soaking, a process that 
also appears to occur through passive diffusion, and causes 
increased  siRNA  mediated  knockdown  (Duxbury  et  al, 
2005).  Thus,  it  is possible  to consider  performing large 
scale  RNAi,  perhaps  by  taking  advantage  of  cell  based 
microarrays and using cell lines that have enhanced RNAi 
sensitivity due to overexpression of the mammalian SIDT1 
(Wheeler et al, 2005).  
 
Mutations in rsd-3 that render mutants defective in sys-
temic RNAi have also been identified (Tijsterman et al, 
2004). The rsd-3 gene encodes a protein with an epsin N-
terminal homology (ENTH) domain; ENTH domains bind 
phosphoinositides, which are often present in vesicle traf-
ficking  domains  (De  Camilli  et  al,  2002).  RSD-3  also 
shares homology with the human protein Enthoprotin (also 
known as Clint and Epsin-R) (Tijsterman et al, 2004). En-
thoprotin co-localises with clathrin and the AP-1 adaptor 
protein and promotes clathrin dependent membrane bud-
ding from the trans-Golgi network (TGN) (Wasiak et al, 
2002; Chidambaram et al, 2004). This raises the possibility 
that  vesicle  trafficking  involving  RSD-3  plays a  role  in 
systemic RNAi, possibly by mediating the transport and 
packaging of dsRNA and/or  siRNA inside the cell. The 
connection between the roles of RSD-3 and SID-1 in sys-
temic RNAi is presently unknown. However, it is likely 
that additional insights into the process of systemic RNAi 
will be provided by characterisation of other genes, which 
when mutated prevent systemic RNAi, such as rsd-2, rsd-3 
and rsd-6 (Tijsterman et al, 2004). 
 
THE ROLE OF ADARs IN RNAi 
 
Adenosine  deaminases  that  act  on  RNA  (ADARs)  edit 
dsRNA  by  converting  adenosines  to  inosines  through 
deamination (Bass, 2002). Thus, RNA editing can produce 
multiple  isoforms  of  the  same  primary  transcript;  the 
greater the extent of base-pairing, the more extensive the 
editing.  One  obvious  implication  of  this  process  is  that 
dsRNAs  modified  by  ADARs  could  potentially  escape 
recognition by Dicer; hence, ADARs could act to suppress 
RNAi.  There  are two  ADARs  in  C.  elegans,  adr-1  and 
adr-2;  however,  contrary  to  initial  expectations,  the  ab-
sence of adr activity failed to enhance the sensitivity of 
RNAi triggered by exogenous dsRNA. However, the ab-
sence  of  adr  activity  specifically  enhanced  RNAi-
dependent co-suppression. It was found that when a trans-
gene carrying a heatshock-driven short sequence-specific 
hairpin RNA (shRNA) was introduced into the adr-1;adr-
2 double  mutant, heat-shock independent co-suppression 
was detected. Subsequently, it was shown that all trans-
genes introduced  into  adr-1;adr-2  null  animals  were  si-
lenced in  somatic tissues.  These  observations led  to the 
hypothesis that in the absence of RNA editing mediated by 
adr-1 and adr-2, leaky transcription from transgenes form 
dsRNA  and  initiate  RNAi  via  Dicer  (Knight  and  Bass, 
2002). Therefore, ADR-1 and ADR-2 could play a protec-
tive role in preventing co-suppression in C. elegans; how-
ever, it appears that co-suppression can still occur if the 
system becomes overloaded with dsRNA from transgenes. 
It is probable that ADARs exert their activity on dsRNA 
generated from transgenes, but not on exogenous dsRNA 
because these proteins are primarily localised to the nu-
cleus and not the cytoplasm (Billy et al, 2001).  
 
Interestingly, animals lacking either adr-1  or  adr-2 also 
suffer  from  olfactory  defects  in  chemotaxis.  Inhibiting 
RNAi by removing rde-1 or rde-4 alleviates this defect, 
suggesting that ADARs could play a special role in the 
nervous  system  by  preventing  endogenously  expressed 
dsRNAs from activating RNAi (Tonkin and Bass, 2003).  
 
Mammals have three ADARs (ADAR1 to ADAR3); ADAR1 
forms two isoforms, ADAR1p150 and ADAR1p110 (for 
review,  see  Valente  and  Nishikura,  2005).  Only 
ADAR1p150 displays a primarily cytoplasmic localisation 
(Patterson and Samuel, 1995).  It has recently been found 
that ADAR1p150  binds siRNA  containing  3’  overhangs 
with  an  extremely  high  affinity, but  does  not  edit  them 
(Yang  et  al,  2005);  A-to-I  editing  by  ADARs  requires 
dsRNA  of  30  bp  or  longer.  Instead,  it  appears  that 
ADAR1p150 acts to sequester siRNAs and prevent them 
from entering the RNAi pathway. In support of this model,  
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Yang et al (2005) showed that the level of siRNA medi-
ated gene silencing was significantly increased in ADAR1
-
/- mouse embryonic fibroblasts. In addition, ADAR1p150 
is the only interferon inducible ADAR, which further sug-
gests that ADARs could play a role in the natural RNAi 
response  in  mammalian  cells  (Patterson  and  Samuel, 
1995).  Expression  of  ADARs  (and  meri-1)  is  also  up-
regulated in response to high concentrations of siRNA in 
mouse  liver  (Hong  et  al,  2005).  In  Xenopus  oocytes, 
ADARs  have  been  further  implicated  in  RNAi  because 
hyper-edited dsRNAs are associated with and degraded by 
the Tudor staphylococcal nuclease (TSN), which is a com-
ponent of the RISC complex (Scadden, 2005).    
 
Hence,  studies  in  worms  and  vertebrates  indicate  that 
ADARs have definite, but distinct roles in RNAi. Unlike 
adr-1  and  adr-2  in  C.  elegans,  which  normally  inhibit 
RNAi  mediated co-suppression caused  by  nuclear  trans-
genes,  the  mammalian  ADAR1p150  appears  to  play  an 
inhibitory role in cytoplasmic RNAi. This raises the possi-
bility that elimination of ADARp150 can be exploited as a 
method  to  improve  the  efficiency  of  performing  RNAi 
screens in mammalian systems.  
 
CHROMATIN REMODELLING AND RNAi 
 
The C. elegans lin-15B gene is a class B synthetic multi-
vulva (synMuvB) gene. Class B genes encode the Retino-
blastoma  (Rb)  tumour  suppressor  orthologue  and  other 
components of the Rb complex. Mutations in these genes 
were  initially  identified  because  animals  carrying  muta-
tions in both synMuvA and synMuvB genes develop cell 
lineage transformations that cause a multivulva phenotype, 
whereas animals carrying a single mutation do not show 
this tranformation (Huang et al, 1994). 
 
Recent studies reveal that C. elegans lacking Rb or Rb 
complex proteins encoded by lin-15B, lin-35, dpl-1, lin-
53,  lin-9,  lin-13  and  hpl-2  show  enhanced  RNAi  re-
sponses  revealed  by  a  decrease  in  the  level  of  target 
mRNA, particularly in the nervous system (Wang et al, 
2005). In addition, these animals show inappropriate ex-
pression of germline activities in somatic tissue, such as 
pgl-1,  which  encodes  an  RNA-binding  component  of 
germline-specific  P-granules,  and ectopic P-granule-like 
structures.  How  does  inhibition  of  the  Rb  pathway  en-
hance RNAi? One hypothesis provided by the authors is 
that de-repression of some RNAi components, which are 
normally  restricted  in  their  activities  to  the  germ  line, 
allows  them  to  function  and  enhance  RNAi  in  somatic 
tissues. Support for this model comes from the observa-
tion that co-suppression associated with a nuclear trans-
gene, which is normally limited to the germ line, is now 
extended to somatic tissues. In addition, the absolute re-
quirement  for  rrf-1  is  relaxed  in  Rb  pathway  mutants, 
suggesting that the germline RdRP, EGO-1, can now act 
redundantly  in  somatic  tissues.  The  de-repression  of 
germline  activities  in  somatic  tissues  also  requires  the 
inappropriate expression of a chromatin remodelling com-
plex defined by MES-4 (Wang et al, 2005).  
 
It has also been suggested that mutations in the Rb path-
way  could  enhance  RNAi  by  alleviating  a  competition 
between the RNAi silencing machinery and the chroma-
tin silencing pathway, so that shared components are re-
directed to perform RNAi. In support of this idea, a mu-
tation  in  the  C. elegans  hpl-2  gene,  which encodes  an 
orthologue  of  the  methylated  histone  binding  protein 
HP1, enhances RNAi and causes transgene de-silencing 
(Couteau et al, 2002; Wang et al, 2005). Moreover, hpl-2 
has been shown to function as a synMuvB gene. In hpl-2 
mutants, pgl-1 is also misexpressed, suggesting that it is 
the combined effect of inappropriately expressing germ-
line components in the soma, as well as releasing RNAi 
components  from  chromatin  remodelling  complexes, 
which is responsible for the enhancement of RNAi. 
 
Combining Rb pathway mutants with previously charac-
terised RNAi enhancer mutants, such as eri-1 and rrf-3, 
synergistically improves RNAi, indicating that the path-
ways  affected  are  independent.  The  potential  for  Rb 
pathway mutants to enhance RNAi in mammalian sys-
tems has yet to be analysed. However, the recent crea-
tion of an Rb knockout mouse makes it possible to ex-
amine  RNAi  enhancing  effects  within  this  system 
(Zhang et al, 2004). 
 
In addition to the genes mentioned in this review, ge-
netic  screens have identified many  more  proteins  with 
possible  roles  in  RNAi,  including  Piwi/PAZ  domain 
proteins, DEAH helicases, RNA binding/processing fac-
tors, chromatin associated factors, DNA recombination 
factors  and  nuclear  import/export  factors(Kim  et  al, 
2005). The range of potential genes that impinge on the 
RNAi process demonstrates the complexity of RNAi and 
its many cell biological roles, which will remain a sub-
ject for future study. 
 
CONCLUSIONS 
 
Since 1998, great strides have been made in elucidating 
the mechanisms underlying RNAi and in identifying the 
genes that participate in the execution and control of this 
process.  Model  organisms,  such  as  C.  elegans,  have 
played vital roles in helping to identify and deduce the 
function of genes involved in RNAi and to order them in 
genetic pathways. Researchers are now learning how the 
RNAi response can be manipulated, so that expression is 
enhanced, inhibited or restricted by cell type, intracellu-
lar compartment or time. Thus, the lessons learned from 
these  models,  particularly  the  worm,  could  be  used  to 
help  researchers  tailor  RNAi  to  perform  optimally  de-
pending on circumstance, which could range from whole 
genome screening to therapeutic intervention. 
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